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Abstract. Obesity induces the formation of reactive oxygen species (ROS) which is 
produce oxidative stress that is involved in various pathological processes such as 
malondialdehyde (MDA) which is a highly toxic molecule. In Indonesia, Muslims are 
fasting for 13-14 hours during Ramadhan. Researchers interested in conducting research on 
the effect of fasting Ramadhan on oxidative stress (MDA levels) in individuals with 
obesity. This research is a prospective cohort. The study was held on  March –  May 2019 
at Outpatient Clinic Endocrinology of RSUP. H. Adam Malik Medan with the approval of 
the FK  USU Research Ethics Commission and according to the criteria of inclusion and 
exclusion. The Data is analyzed by using the SPPS program where p < 0.05 is considered 
significant. The results of the study obtained a meaningful decline in the level of MDA 
before and after the fasting of Ramadhan (p < 0.001). The median rate of MDA before 
Ramadhan was 4.88 nmol/ml (1.68-101,5 nmol/ml) and after Ramadhan fasting the median 
rate of MDA became 3.96 nmol/ml (0.97-92,20 nmol/ml). There was decreased of 
oxidative stress parameter MDA levels after Ramadhan fasting in obese patients. 
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Abstrak. Obesitas menginduksi pembentukan reactive oxygen species (ROS) yang 
kemudian menghasilkan stres oksidatif yang terlibat pada berbagai proses patologis, 
seperti malondialdehyd (MDA) yang merupakan molekul yang sangat toksik. Di Indonesia, 
Muslim berpuasa selama 13-14 jam selama Ramadhan.. Peneliti tertarik untuk melakukan 
penelitian mengenai efek puasa ramadhan terhadap stres oksidatif (kadar MDA) pada 
individu dengan obesitas. Penelitian ini merupakan kohort prospektif.Penelitian 
dilaksanakan Maret –  Mei 2019 di Poliklinik Rawat Jalan Endokrin  RSUP.H. Adam Malik 
Medan dengan persetujuan Komisi Etik Penelitian FK USU dan sesuai kriteria inklusi dan 
eksklusi. Data dianalisis dengan menggunakan program SPPS di mana p<0,05 dianggap 
signifikan. Dari hasil penelitian didapatkan  penurunan bermakna kadar MDA sebelum 
dan setelah puasa Ramadhan (p<0,001). Median kadar MDA sebelum puasa Ramadhan 
adalah 4,88 nmol/ml (1,68-101,5 mol/ml) dan setelah puasa Ramadhan median kadar MDA 
menjadi 3,96 nmol/ml (0,97-92,20 nmol/ml). Didapatkan penurunan parameter stres 
oksidatif MDA setelah puasa Ramadhan pada pasien Obesitas. 
Kata kunci: Puasa-Ramadhan, Obesitas, MDA, ROS 
Received 11 April 2020 | Revised 22 April 2020 | Accepted 11 May 2020 
Journal of Endocrinology, Tropical Medicine, and Infectiouse Disease (JETROMI) Vol. 02, No. 2, 2020                        72                                                          
 
1 Introduction 
Obesity is one of the diseases that is a problem of the world nowadays where it is a complex 
multifactorial disease. Globally, there were 1.9 billion and 609 million obese and overweight 
suffers in 2015, responsively reaching 39 % of the world’s population. In Southeast Asia 
prevalence of obesity also increased from 1.7 % (1980) to 6.2 % (2015) [1]. Obesity is also a 
serious problem in Indonesia with a prevalence of 23.1% of population [2].  Obesity is a chronic 
disease that is marked by an increase in body fat which not only functions as storage of 
triglycerides but also produces bioactive substances such as adipokines, IL-6 and leptin. 
Adipokines induces the formation of reactive oxygen species (ROS) which is produce oxidative 
stress that is involved in various pathological processes [3]. Some of the known oxidative stress 
biomarkers are malondialdehyde (MDA) which is a highly toxic molecule and its interactions 
with DNA and proteins can be carcinogenic, mutagenic and atherogenic. To minimize the 
effects of these free radicals there is an an antioxidant complement system that protecs organism 
by preventing by preventing the formation of free radicals such as glutathione peroxidase 
(GSH-Px), glutathione-S transferase (GST), superoxide dismutase (SOD), catalase (CAT), 
vitamin A, E and C [3].  
Ramadhan fasting is one of the pillars of Islam that must be implemented by every Muslim 
around the world for a full month during the month of Ramadhan (Hijri calendar). In Indonesia, 
Muslims are fasting for 13-14 hours. In addition to holding food and drinking, during fasting is 
also forbidden to smoke, sexual intercourse and is encouraged to resist emotions [4]. Fasting or 
Intermittent Fasting (IF) may decrease inflammation and the oxidative stess via an autophagyi 
activation. IF  lowers insulin levels in circulation and fasting blood sugar levels, parallel to the 
increased concentration of growth hormone and insulin sensitivity. IF is an effect on the 
cardiovascular system by lowering blood pressure, cholesterol concentration, LDL, and 
triglycerides. IF also relates to weight loss and abdominal fat so as to fix the metabolic marker 
significantly. The effect of Ramadhan intermittent fasting (RIF) on oxidative stress is still 
unclear and there is a difference among some research based on the background above the 
researchers interested in conducting research on the effect of fasting Ramadhan on oxidative 
stress MDA levels in individuals with obesity [5]. 
2 Methods 
The study design was a prospective cohort observational study with the independent variable 
being Ramadhan fasting and the dependent variable was lipid profile and MDA levels. The 
study was conducted at the endocrine outpatient clinic at Haji Adam Malik General Hospital 
Medan from March to May 2019 with a total sample of 30 patients according to inclusion and 
exclusion criteria. The sample collection in this study was carried out using the purposive 
sampling method. Every patient who came to Haji Adam Malik General Hospital who was 
obese in accordance with the study criteria was taken as a sample. After fulfilling the study 
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criteria, the patient fills out the consent letter after receiving an explanation. The study sample 
was chosen consecutively for patients who met the criteria, until the required number of samples 
were met. Then anthropometric examination will be carried out by measuring body weight, 
height, BMI, waist size, hip size and examination of lipid profiles (total cholesterol, Low 
Density Lipoprotein cholesterol (LDL-C), and High Density Lipoprotein cholesterol (HDL-C)) 
and MDA. The relationship between the results of atropometric examination, hemodynamics, 
lipid profile and MDA levels before and after Ramadhan fasting in obese patients will be 
analyzed using the Wilcoxon test. 
While the relations between changes in BMI with lipid profile levels and MDA will be analyzed 
using the Spearman correlation. All analyzes were guided by a two-way hypothesis test and had 
a 95% CI. A p value of ≤ 0.05 was considered statistically significant. Analysis and presentation 
of data used statistical analysis with the Stastical Product and Service Solution (SPSS) 22.0 
software for windows. To assess whether the sample is in a normal distribution or not using the 
Shapiro-Wilk test, if the number of samples is below fifty. Data is prepared in the form of mean 
± standard deviation if the data distribution is normal, if not the normal distribution is presented 
in the form of a median (min-max). Acceptance criteria include subjects aged 40-65 years, both 
men and women who fast during the month of Ramadhan (13-14 hours) and have 2 meals (30 
minutes before sunrise and 30 minutes before sunset), obese patients (BMI ≥ 25 kg / m2), 
receive information and consent to participation is voluntary and written to undergo a known 
physical and laboratory examination and approved by the health research ethics committee, and 
does not include rejection criteria such as patients taking long-term drugs (hormonal drugs, 
corticosteroids, anti-diabetic drugs, cholesterol-lowering drugs), patients with infections or a 
history of previous infections, patients with myocardial infarction , inflammatory arthritis and 
malignancy, sufferers of systemic disease ( such as Diabetes Mellitus, Chronic Kidney Disease) 
and hormonal diseases (thyroid disease, growth hormone disorders, reproductive disorders and 
adrenal hormone disorders), patients who consumed alcohol during the study period, patients 
who took drugs or herbs for the purpose of losing weight or other dietary methods, patients were 
not cooperative as well as pregnant patients. 
3 Result 
3.1 Characteristics of research subjects 
A total of 30 obese subjects who met the inclusion and exclusion criteria participated in this 
study (table 1). The mean systolic blood pressure was 120.8 (111.6 – 130) mmHg. The mean 
diastolic blood pressure in the study subjects was 82.4 (72.6 – 92.2) mmHg. The median BMI 
value in this study was 29.2 (25.2-42.5) kg / m2. The mean waist size is 100.9 (87.4 – 114.4) 
cm, the mean hip size is 110.3 (99.5 - 121.1) cm. The median ratio of waist and hip size is 
1.03 (0.92-1.08). The mean total cholesterol level was 199.7 (165.3 – 234.1) mg / dL, the 
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mean HDL level was 49.4 (41.2 – 57.6) mg / dL, the average LDL level was 130.1(101.7 – 
158.5) mg / dL. The mean HDL / total cholesterol ratio was 0.26 (0.19 – 0.33). Median MDA 
level of 4.88 (1.68-101.5) nmol / mL. 
Table 1. Characteristics of Research Subjects 
Characteristics n=30 
med (min-max) 
Gender  
Male 27 (90%) 
Female 3 (10%) 
Age (year)a 27.2 (23.3 – 31.1) 
Height (cm)a 170,6 (163.9 – 177.3) 
Body weight (kg)a 90.8 (72.2 – 109.4) 
BMI (kg/m2)b 29.2 (25.2-42.5) 
Waist size(cm)a 100.9 (87.4 – 114.4) 
Hip size (cm)a 110.3 (99.5 - 121.1) 
Waist/hip ratiob 1.03 (0.92 -1.08) 
SBP (mmHg)a  120.8 (111.6 – 130) 
DBP (mmHg)a 82.4 (72.6 – 92.2) 
TC (mg/dL)a 199.7 (165.3 – 234.1) 
HDL-C (mg/dL)a 49.4 (41.2 – 57.6) 
LDL -C  (mg/dL)a 130.1(101.7 – 158.5) 
HDL/TC ratio 0.26 (0.19 – 0.33) 
MDA(nmol/mL) 4.88 (1.68-101.5) 
                 BMI: body mass index; SBP : Systolic Blood Pressure DBP : Diastolic Blood Pressure BMI:  
                   body mass index; TC: total cholesterol; HDL-C: High Density Lipoprotein cholesterol,                 
                   LDL-C Low Density Lipoprotein cholesterol;  MDA: malondialdehyde 
 
3.2 Changes in Hemodynamic and Anthropometric Parameters Before and After 
Ramadhan Fasting in Research Subjects 
Changes in hemodynamic and anthropometric parameters before and after Ramadhan fasting 
can be seen in table 2. 
 
Table 2. Changes in Hemodynamic and Anthropometric Parameters Before and After 
Ramadhan Fasting in Research Subjects 
Characteristic p1 
med (min-max) 
p2 
med (min-max) 
P 
SBP (mmHg)a  120.8 (111.6 – 130) 119.7 (108.4 – 131)  0.475 
DBP (mmHg)a 82.4 (72.6 – 92.2) 81.1 (70.6 – 91.6) 0.417 
Body weight (kg)a 90.8 (72.2 – 109.4) 89.4 (70.9 – 107.9) 0.001** 
BMI (kg/m2)b 29.2 (25.2-42.5) 28.8 (25.1-42.0) 0.001** 
Waist size (cm)a 100.9 (87.4 – 114.4) 98.7 (86.7 – 110.7) 0.016* 
Hip size (cm)a 110.3 (99.5 – 121.1) 108.3 (98.1 – 118.5) 0.005* 
Waist/Hip ratiob 1.03 (0.92-1.08) 0.92 (0.80-1.01) 0.001** 
BMI: body mass index; SBP : Systolic Blood Pressure DBP : Diastolic Blood Pressure 
*p<0.05; **p<0,001; p1 before Ramadhan fasting, p2 after Ramadhan fasting 
 
There were significant differences in body weight and BMI of research subjects before and after 
Ramadhan fasting (p <0.001 and p <0.05) (Table 2). where the mean weight of the study 
subjects before Ramadhan fasting was 90.8 (72.2–109.4) kg and after Ramadhan fasting 
Journal of Endocrinology, Tropical Medicine, and Infectiouse Disease (JETROMI) Vol. 02, No. 2, 2020                        75                                                          
 
becomes 89,4 (70.9–107.9). From BMI, the median BMI of research subjects before Ramadhan 
fasting was 29.2 (25.2-42.5) kg / m2 and after Ramadhan fasting it became 28.8 (25.1-42.0) kg / 
m2. There was a statistically significant weight loss and BMI after the fasting of Ramadhan. 
 
Waist size, hip size, and waist / hip size ratio of study subjects before and after Ramadhan 
fasting also showed a significant decrease. The mean waist size of the study subjects before 
Ramadhan fasting was 100.9 (87.4 – 114.4) cm and after Ramadhan fasting it became 98.7 (86.7 
– 110.7) (p = 0.016). The mean hip size of the study subjects before Ramadhan fasting was 
110.3 (99.5 – 121.1) cm changed to 108,3 (98.1–118.5) (p = 0.005) after Ramadhan fasting. The 
median waist-to-hip size ratio of study subjects before Ramadhan fasting was 1.03 (0.92-1.08) 
and after Ramadhan fasting to 0.92 (0.80-1.01) (p <0.001) 
 
3.3 Changes in Laboratory Parameters Before and After Ramadhan Fasting        
Changes in laboratory parameters before and after Ramadhan can be seen in table 3. 
 
Table 3. Changes in Lipid Profile and MDA Levels Before and After Ramadhan Fasting in 
Research Subjects 
Characteristic P1 
med (min-max) 
P2 
med (min-max) 
P 
TC (mg/dL)a 199.7 (165.3 – 233.8) 185.5 (150.3 – 220.2) 0.001* 
HDL-C (mg/dL)a 49.4 (41.2 – 57.6) 52.5 (44  - 61) 0.049* 
LDL-C  (mg/dL)a 130.1 (101.7 – 158.5) 129.0 (96.1 - 161.9)  0.729 
HDL-C /TC ratioa 0.26 (0.19 – 0.33) 0.30 (0.21 – 0.39) 0.021* 
MDAb 4.88 (1.68-101.5) 3.96 (0.97-92.2) 0.001** 
TC:Total Cholesterol; HDL-C: High Density Lipoprotein Cholesterol; LDL-C : Low Density Lipoprotein 
Cholesterol; MDA : Malondialdehyde; a normal distribution; mean deviation; paired t testb a abnormal 
distribution ; median (min-max); Wilcoxon test 
*p<0.05; **p<0.001; P1 before Ramadhan fasting; P2 after Ramadhan fasting 
 
Significant differences in total cholesterol, HDL-C, and HDL-C/ cholesterol total ratios were 
observed before and after Ramadhan fasting (p <0.001; p = 0.049; p = 0.021) (table 3). The 
mean total cholesterol level of the study subjects before Ramadhan fasting was 199.7 (165.3 – 
233.8) mg / dL and after Ramadhan fasting it became 185.5 (150.3 – 220.2) mg / dL. The mean 
HDL-C level of the study subjects before Ramadhan fasting was 49.4 (41.2 – 57.6) mg / dL and 
after Ramadhan fasting it became 52.5 (44  - 61) mg / dl. The mean HDL-cholesterol ratio of the 
total study subjects before Ramadhan fasting was  0.26 (0.19 – 0.33) and after Ramadhan 
fasting it became 0.30 (0.21 – 0.39). 
 
A significant decrease in MDA levels was found before and after Ramadhan fasting (p <0.001). 
The median MDA level before Ramadhan fasting is 4.88 (1.68-101.5) and after Ramadhan 
fasting the median MDA level is 3.96 (0.97-92.20). 
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3.4 Differences in Anthropometric Changes and Laboratory Parameters Before 
and After Ramadhan Fasting by Tarawih Category  
Differences in anthropometric changes and laboratory parameters before and after Ramadhan 
fasting based on tarawih categories can be seen in table 4. 
 
Table 4. Differences in anthropometric changes and laboratory parameters before and 
after Ramadhan fasting based on tarawih categories 
Characte 
ristic 
<15 days  >15 days   
Δ p 
 Before 
Med (min-max) 
After 
Med (min-max) 
Δ P1 Before 
Med (min-max) 
After 
Med (min-max) 
Δ P2  
BW 
(kg)a 
93.4 
(73.4 – 113.4) 
92.4 
(72.2 – 112.6) 
-1.03 0.026* 88.2 
(70.9 – 105.5) 
86.3 
(69.6 – 103) 
-1.93 
 
0.001** 0.088 
BMI 
 (kg/m2)a 
31.6±5.7 
(25.9 – 37.3 
31.3 
(25.5 – 37.1) 
- 0.35 0.033* 30.4 
(26.1 – 34.7) 
29.8 
(25.5 – 34) 
0.68 
 
0.001** 0.939 
Waist size  
(cm) a 
102.2 
(86.7 – 117.7) 
100.0 
(86.1 – 113.9) 
-2.2 
 
0.147 99.6 
(88.1 – 111.1) 
97.5 
(87.4 – 107.6) 
-2.1 
 
0.039* 0.530 
Hip size  
(cm)a 
110.7 
(98.9 – 122.5) 
108.2 
(97 – 119.4) 
-2.5 
 
0.028* 109.9 
(99.8 – 120) 
108.3 
(98.7 – 117.9) 
-1.6 
 
0.102 0.077 
TC  
(mg/dL)a 
200.6 
(173 – 228.2) 
190.2 
(166.5 – 213.9) 
-10.4 0.021* 198.9 
(157.7 – 240.1) 
180.7 
(136.5 – 224.9) 
18.1 
 
0.019* 0.339 
HDL_C 
(mg/dL)a 
50.5 
(44 – 57) 
52.9 
(45.4 – 60.4) 
2.3 0.075 48.3 
(38.6 – 58) 
52.1 
(42.4 – 61.8) 
3.8 
 
0.192 0.634 
LDL-C  
(mg/dL) a 
131.9 
(109.8 – 154) 
131.0 
(107.1 – 154.9) 
-0.9 0.769 128.3 
(94.1 – 162.5) 
127.1 
(86.3 – 167.9) 
-1.2 
 
0.826 0.917 
MDA 
(nmoL/mL) b 
3.92 
(2.31 - 101.5) 
3.45 
(1.97 - 92.2) 
-0.71 0.001* 5.3 
(1.68 -100.9) 
4.7 
(0.97-71.07) 
-0.97 
 
0.001* 0.171 
BW: body weight; Lipoprotein Cholesterol; MDA : Malondialdehyde; 
a normal distribution; mean deviation; paired t test; b a abnormal distribution ; median (min-max); Wilcoxon test; P1 
before Ramadhan fasting; P2 after Ramadhan fasting; Δ p: P1 vs P2 
*p<0.05; **p<0.001; P1 before Ramadhan fasting; P2 after Ramadhan fasting 
 
Significant differences in body weight were found before and after Ramadhan fasting both in 
groups with tarawih less than 15 days and in the tarawih group for more than 15 days (p = 0.026 
vs p <0.001). We found a higher weight loss in the group with tarawih more than 15 days 
compared to the group with tarawih less than 15 days (1,93 (0.83 – 3.03) vs 1.03 (0.57) – 2.63) . 
but this difference was not statistically significant (p = 0.088). 
 
Significant differences in body mass index were found before and after Ramadhan fasting both 
in groups with tarawih less than 15 days and in the tarawih group for more than 15 days (p = 
0.033 vs p <0.001). A decrease in body mass index was found to be higher in the group with 
tarawih more than 15 days compared to the group with tarawih for less than 15 days (0,68 (0.3 – 
1.06) vs. 0,35  (0.22 – 0.92), but this difference was not statistically significant (p = 0.939). 
 
Significant differences in waist size before and after Ramadhan fasting were found in groups 
with tarawih for more than 15 days, but no significant differences in waist size in the tarawih 
group were less than 15 days (p = 0.039 vs p = 0.147). The decrease in waist size was found to 
be higher in the group with tarawih less than 15 days compared to the group with tarawih for 
more than 15 days 2.2 (3.4 – 7.8) vs 2,1 (1.4 – 5.6), but this difference was not statistically 
significant (p = 0.530). 
 
Significant differences were found in total cholesterol before and after Ramadhan fasting both 
in groups with tarawih less than 15 days and in the tarawih group for more than 15 days (p = 
0.021 vs p = 0.019). The decrease in total cholesterol was found to be higher in the group with 
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tarawih more than 15 days compared to the group with tarawih for less than 15 days 18.1 (8.4 – 
44.6) vs 10.4 (5.1 – 25.9). but this difference was not statistically significant (p = 0.339). 
 
No significant differences were found in HDL before and after Ramadhan fasting both in groups 
with tarawih less than 15 days and in the tarawih group for more than 15 days (p = 0.075 vs p = 
0.192). The increase in HDL was found to be higher in the group with tarawih more than 15 
days compared to the group with tarawih for less than 15 days: 2.3 (2.4 – 7) vs 3.8 (7 – 14.6), 
but this difference was not statistically significant (p = 0.634 ). 
 
No significant differences were found in LDL levels before and after Ramadhan fasting both in 
groups with tarawih less than 15 days and in the tarawih group for more than 15 days (p = 0.769 
vs p = 0.826). The decrease in LDL levels was found to be higher in the group with tarawih 
more than 15 days compared to the group with tarawih for less than 15 days:  0.9  vs 1,2. 
 
Significant differences were found in MDA levels before and after Ramadhan fasting both in 
groups with tarawih less than 15 days and in the tarawih group for more than 15 days (p 
<0.001). The decrease in MDA levels was found to be higher in the group with tarawih more 
than 150 days compared to the group with tarawih for less than 15 days: 0.97 vs 0.71, but this 
difference was not statistically significant (p = 0.171) 
 
 
3.5 Correlation of BMI Change with Lipid Profile and MDA 
No correlation was found with changes in BMI and the relation in lipid profile. and MDA 
(Table 5) 
Table 5.  Correlation of BMI Change with Lipid Profile and MDA 
Variabel BMI Changes  
 R P 
TC changes 0.178 0.348 
HDL-C Changes 0.044 0.819 
LDL-C Changes -0.052 0.785 
MDA Changes 0.141 0.456 
*Spearman Correlation 
TC: total cholesterol; HDL-C: High Density Lipoprotein cholesterol, LDL-C: Low Density Lipoprotein cholesterol;  
MDA: malondialdehyde 
 
 
3.6 Correlation of MDA Change with Lipid Profile 
 
From the research. it was found that there was no correlation between changes in MDA and 
changes in lipid profile (Table 6) 
 
Table 6. Correlation of Changes in MDA with Changes in Lipid Profile 
Spearman Correlation MDA Changes  
 R P 
TC 0.022 0.906 
HDL C -0.094 0.620 
LDL C 0.150 0.428 
*Spearman Correlation 
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TC: total cholesterol; HDL-C: High Density Lipoprotein cholesterol, LDL-C: Low Density Lipoprotein cholesterol;  
MDA: malondialdehyde 
4 Discussion 
Obesity is a disease that’s become a global problem today. Increased prevalence of obesity from 
year to year is accompanied by an increased incidence of diseases where obesity is a risk factor, 
such as heart disease, diabetes, and cancer [1]. Obesity occurs as a result of an imbalance in 
energy intake and expenditure characterized by a BMI ≥ 25 kg / m2 [6]. In obesity there can be 
disruption in the regulation of fatty acids which will increase triglyceride and ester cholesterol 
levels so that obese people are more likely to have an increase in blood triglycerides, LDL 
cholesterol and decreased HDL cholesterol [7]. Obesity is associated with high calorie intake, 
which causes an increase in blood sugar and free fatty acids in the circulation. Lipids are one of 
the most sensitive molecules to free radical attack which can form lipid peroxide. Lipid 
peroxidation is a reaction that occurs between free radicals and polyunsaturated fatty acids. The 
final product of lipid peroxidation is MDA, and is usually used as a biological biomarker of 
lipid peroxidation to assess oxidative stress and free radicals [8]. Ramadhan fasting / Ramadhan 
intermittent fasting (RIF) is a unique dietary model in the form of restrictions on eating and 
drinking for 12-18 hours a day for 29-30 days per year, namely in the month of Ramadhan. 
Ramadhan fasting is interesting to explore its effects on anthropometric, biochemical and 
oxidative stress parameters. During Ramadhan fasting, lifestyle modification and special dietary 
methods include changes in frequency and eating schedule, sleep patterns and increased 
physical activity during tarawih prayer. Several studies have revealed the effect of Ramadhan 
fasting on weight loss, improvement of lipid profile, pro-inflammatory cytokines (IL-1, Il-6, 
TNF-α) and on oxidative stress markers MDA both in obese and normal individuals. Based on 
the characteristics of the research subjects (Table 1) the majority of subjects were male, totaling 
27 people (90%) while female subjects only 3 people (10%). The mean age of the subjects was 
27.2 (23.3 – 31.1) years. This is in accordance with research conducted by Chooi et al in 
2018where globally there was an increase in the prevalence of obesity and overweight in both 
men and women over the age of 20 years and peaked at the age of 50 - 65 years, then decreased 
thereafter [1]. 
In this study, changes in anthropometric parameters were found before and after Ramadhan 
fasting (Table 2). The mean weight of the study subjects decreased from  90.8 (72.2 – 109.4) kg 
before fasting  to 89.4 (70.9 – 107.9) kg after Ramadhan fasting. This weight loss correlates 
with a decrease in BMI, from a median BMI of  29.2 (25.2-42.5) kg / m2 to 28.8 (25.1-42.0) kg 
/ m2 after Ramadhan fasting. This is in line with a systematic review and meta-analysis by 
Fernando et al who reviewed 90 studies with 2947 participants. In that study it was found that 
Ramadhan fasting induces a temporary weight loss of 1.07 - 1.61 kg significantly (p <0.001) 
compared to the initial value. Weight loss was found to be greater in subjects with high initial 
BMI values. At the next follow-up after the completion of Ramadhan, weight loss was still 
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found by 0.2-0.9 kg compared to the initial value [9]. Shariatpanahi et al also found a significant 
decrease in BMI and waist size after Ramadhan fasting (p <0.001) by 3.3% and 2.7% 
respectively from the initial values [10]. In this study found a significant reduction in waist size, 
hip size and waist / hip size ratio in obese subjects. This is in line with the research of Celik et al 
who found a decrease in waist size (p <0.001), pelvic size (p = 0.001) and hip / hip size ratio (p 
= 0.005) after Ramadhan fasting in both normal and obese individuals. But in that study, when 
obese subjects were grouped separately, a significant decrease was only found in waist size (p = 
0.041), whereas a decrease in hip size (p = 0.063) and hip size ratio (p = 0.102) were not 
significant [11] . 
From the study it was found that the mean decrease in systolic blood pressure and diastolic 
blood pressure in the study subjects before and after Ramadhan fasting, but not significant (p 
0.475 and p 0.417) (Table 2). The mean systolic blood pressure before Ramadhan fasting 120.8 
(111.6 – 130) and after Ramadhan fasting 119.7 (108.4 – 131) with the mean diastolic blood 
pressure before Ramadhan fasting was 82.4 (72.6 – 92.2)  and after Ramadhan fasting 81.1 
(70.6 – 91.6). This is in accordance with research conducted by Mughni, 2007 which is 
associated with self-control during one month of fasting. the body will be released adrenaline or 
epinephrine which will cause blood vessels to narrow and blood pressure will rise [12]. 
Lipid profiles in the subjects of this study improved with a decrease in total cholesterol (p = 
0.001), an increase in HDL (p = 0.049) and a significant ratio of HDL / cholesterol (p = 0.021) 
(Table 3). The increase in HDL and reduction in total cholesterol found in this study is in line 
with other studies. Some of these studies also found a decrease in triglycerides and LDL 
[4],[10],[13]-[15]. Some studies conclude that changes in lipid profile depend on changes in 
body weight [14]. 
Mazidi et al in his systematic review of studies relating to Ramadhan fasting and lipid profiles 
from 1984 to 2014 found that 9 studies found significant HDL increases during Ramadhan 
fasting. On the other hand, there are 2 studies which found a decrease in HDL during fasting 
[13]. Shehab et al found changes in HDL-C during Ramadhan fasting in both men and women 
[4]. Likewise with Shariatpanahi et al who found the mean HDL before Ramadhan fasting 41.53 
± 5.45 rose to 46.66 ± 5.50 after Ramadhan fasting (p = 0.002) [4]. HDL causes dangerous lipid 
movement, especially excess choleterol and from peripheral tissue to be stored in the liver. HDL 
also inhibits LDL aggregation enzymatically, improves blood vessel reactivity with vasodilation 
induced by nitric oxide production, inhibits inflammation, chemotaxis and thrombosis. HL also 
facilitates the transfer of macrophages out of the arterial blood vessel wall [16]. Increasing HDL 
through fasting or with similar dietary methods can be an additional modality for increasing 
HDL that is not achieved with medication alone [14]. 
Ramadhan fasting can reduce total cholesterol as found in this study. A systematic review by 
Mazidi et al found 5 studies getting a reduction in total cholesterol after Ramadhan fasting while 
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2 studies found the opposite [13]. Serum cholesterol may go down a few days at a time of 
fasting and may increase a few days after Ramadhan fasting. Increases in cholesterol and LDL 
concentrations have been reported by several researchers. This increase may be related to 
weight loss during Ramadhan fasting. Nevertheless there are also researchers who found a 
decrease in cholesterol levels during Ramadhan fasting. The reduction in total cholesterol 
during Ramadhan fasting may be related to the frequency of large meals which are reduced to 
twice a day [17]. 
As previously explained, that cellular systems produce oxidants and tissues of the human body 
are affected by the balance between oxidant production and defense mechanisms in the form of 
antioxidants. Oxygen molecules have a high affinity for lipids. The bond between oxygen and 
double-chain saturated fatty acids causes a chemical reaction called lipid peroxidation. 
Increased lipid peroxidation is an indirect indicator of increased free radical activation. In this 
study found a decrease in median MDA levels before and after fasting from 4.88 (1.68-101.5) to 
3.96 (0.97-92.2) with a significant p <0.001. The decrease in MDA levels correlated 
significantly with the decrease in IL-6 levels after fasting (r = 0.37; p = 0.044). The decrease in 
median MDA levels before and after Ramadhan fasting shows that Ramadhan fasting is proven 
to reduce lipid peroxidation and oxidative stress in people with obesity. During Ramadhan 
fasting, changes in eating and drinking time, reduction in eating frequency, changes in sleep 
patterns cause various biological changes such as the circadian distribution of body temperature, 
melatonin, cortisol and glycemic control. These physiological changes have been reported to 
modulate levels of inflammatory markers and oxidative stress in the human body. This is in line 
with the research of Asgary et al. In that study, MDA levels dropped significantly from 1.9 
(1.39 - 2.41) to 1.73 (1.35 – 2.11) after Ramadhan fasting (p = 0.009). A decrease in MDA 
levels indicates a decrease in lipid peroxidation. Ramadhan fasting is assumed as one of the 
ways to prevent coronary heart disease where the process of atherosclerosis in the walls of the 
coronary arteries is triggered by the oxidation of fatty acids and LDL-C. Lipid peroxidation 
products (conjugated dienes) were also examined in the study but no significant changes were 
found 
Faris et al in a meta-analysis concluded Ramadhan fasting has an effect on decreasing oxidative 
stress markers, although these changes are relatively small, this shows that Ramadhan fasting 
causes short-term protection in warding off oxidative stress and pro-inflammatory states [18] . 
The reduction in oxidative stress markers is in line with weight loss as found in this study. This 
is in line with research by Faris et al. That an increase in body weight and total body fat is 
associated with an increase in levels of inflammatory markers and oxidative stress in the human 
body, and vice versa [18]-[19] 
Obesity can cause oxidative stress through activation of intracellular pathways such as 
nicotinamide adenine dinucleoside phosphate (NADPH), oxidase (NOX), oxidative 
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phosphorylation in mitochondria, glyoxidation, protein kinase C and polyols. This can interfere 
with the regulation of adipokin synthesis such as adiponectin, visfatin, resistin, leptin, 
plasminogen activator inhibitors (PAI-1), TNF-α and IL-6. TNF-α and IL-6 can increase NOX 
activity and superoxide anion production. It seems that obesity is a link between oxidative stress 
and inflammation although it is not easy to confirm which one is firs. In a study conducted by 
Manna and Jain, 2015 reported that low levels of antioxidant molecules were found in obese 
subjects in line with an increase in antioxidant enzymes [20] 
Although the majority of studies found a decrease in MDA, but there are also studies that 
contradict the results of this study. Ibarahim et al in his study did not get a significant decrease 
in MDA (before fasting 1.41 (1.28 – 1.72) ; after fasting 1.31 (0.8 – 1.46), p> 0.05), but MDA 
levels in erythrocytes were found to decrease significantly (before fasting 2.62 (2.39 – 2.85), 
after fasting 2.40 (2.24 – 2.56), p <0.05) [21]. In that study, there were also no changes in 
anthropometric parameters (body weight and BMI) and body fat mass before and after fasting. 
As explained above, this might explain why serum MDA levels also don't change. In addition, 
there are factors that influence lipid peroxidation such as the type of fat intake (saturated fat or 
unsaturated fat), intake of exogenous antioxidants and the production of endogenous 
antioxidants that are not controlled in this study (Ibrahim et al, 2008). Bahammam et al 
hypothesized in their research report regarding the effects of Ramadhan fasting on oxidative 
stress namely that the effect of Ramadhan fasting on oxidative stress would be greater if calorie 
and fat intake was restricted, sleep duration and physical activity were regulated. However, in 
the pilot study, although some factors have been regulated, it was found that MDA levels did 
not change significantly in both obese and non-obese individuals [22] 
There were some significant differences found in body weight before and after Ramadhan 
fasting both in groups with tarawih less than 15 days and in the tarawih group for more than 15 
days (p = 0.026 vs p <0.001). Found significant differences in body mass index before and after 
Ramadhan both in groups with tarawih less than 15 days and in the tarawih group more than 15 
days (p = 0.033 vs p <0.001). Significant differences were found in total cholesterol before and 
after Ramadhan fasting both in groups with tarawih less than 15 days and in the tarawih group 
for more than 15 days (p = 0.021 vs p = 0.019). 
Significant differences were found in MDA levels before and after Ramadhan fasting both in 
groups with tarawih less than 15 days and in the tarawih group for more than 15 days (p 
<0.001). The decrease in MDA levels was found to be higher in the group with tarawih more 
than 15 days compared to the group with tarawih for less than 15 days (0.97 vs -0.71), but this 
difference was not statistically significant (p = 0.171) (Table 3.4). 
The difference in results might be influenced by differences in food type, calorie intake, level of 
physical activity during Ramadhan fasting, because some people decrease their physical activity 
during the month of Ramadhan, while others routinely perform tarawih prayers during the same 
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month of Ramadhan as moderate physical activity [14]. The heterogeneity of the findings above 
regarding the effect of Ramadhan fasting on MDA may be influenced by various factors, 
including the age of the subject, geographical diversity, differences in culture and type of food, 
daytime temperatures, fasting duration, differences in habits during Ramadhan, calorie intake 
and fluid, duration and pattern of sleep and level of physical activity [18] 
From this study, it was found that there was no correlation between changes in BMI with 
changes in lipid profiles. No correlation was found with changes in BMI with changes in total 
cholesterol, HDL, and HDL (p = 0.348, p = 0.819, p = 0.785). Unrelated correlations can be 
caused by changes in the regimen / type of food consumed during Ramadhan, a decrease in 
activity, and several other kutural parameters. The same results were obtained in a study 
conducted by Ahmadinejad, Z. et al, 2006 which found no correlation between changes in 
cholesterol levels and changes in anthropometric factors examined. This can be due to the use of 
stored body fat and the synthesis of newly formed fats into the greatest source of energy in 
certain circumstances (Ramadhan fasting) compared to normal energy intake conditions which 
increase the fat element in circulation.Furthermore according to research conducted by Moore, 
RB, 1998, it was found that when food energy intake was near the required levels, dietary fat 
and blood cholesterol levels had a positive relationship [23] 
Ahmadinejad, Z, et al  in 2006 found a significant decrease in HDL-cholesterol and a significant 
increase in LDL cholesterol which is a picture of total energy intake and type of dietary fat 
consumed. Other studies have found elevated levels of LDL cholesterol when eating diets 
contain saturated fatty acids. There is research that states a decrease in LDL cholesterol is 
accompanied by a decrease in total blood cholesterol levels, but an increase in total cholesterol 
without changes in total cholesterol has been observed [23] 
From this study, it was found that there was no correlation between changes in BMI and MDA 
changes. The study of  Klop et al  in (2012)  and Roky et al in  (2004) reported differences in 
habits and biologics, such as circadian rhythms, body temperature, melatonin, cortisol and blood 
sugar levels and also changes in sleep and wakefulness which gave different levels of serum 
MDA. These physiological changes are reported to modulate levels of inflammatory markers 
and oxidative stress in the human body [24]-[25] 
Bajpai, A., in 2014 study conducted in patients with depression and controls with the same 
research subjects found there was a significant increase in serum MDA levels in subjects with 
depression when compared with healthy controls. Psychological stress is a prolonged factor 
causing major depression, which tends to increase MDA levels, oxidative stress, and depressive 
symptoms [26] 
No correlation was found with changes in MDA with changes in lipid profiles in this study. 
Oxidative stress occurs when there is excess oxygen radicals produced by cells, which cannot 
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compensate for the normal antioxidant capacity. When the concentration of reactive species 
cannot be controlled by internal defense mechanisms such as antioxidants (tocopherol, ascorbic 
acid, and glutathione) or enzymes which include oxygen radicals (catalase, peroxidase, and 
superoxidase dismutase, SOD), oxidative damage occurs in proteins, fats and DNA which can 
trigger cytotoxicity, genotoxicity, and even carcinogenesis when damaged (mutated) cells that 
can proliferate. This can cause no significant relationship between changes in BMI and MDA 
changes because when an oxidative stress occurs it will be followed by an antioxidant release 
[27]. 
Based on the researchers' assumptions, there is no correlation between changes in MDA and 
changes in lipid profiles due to many factors. Different food intake where the tendency for the 
type of fat consumed can affect MDA levels. Tarawih Prayers that can affect MDA levels given 
the influence of psychological factors can affect MDA levels. When fasting, fasting people 
become more sincere, trusting, calm and patient which according to researchers can reduce 
levels of oxidative stress. The strength of this study is that it is the first study to assess changes 
in lipid profile and MDA levels in obese patients who are fasting in Ramadhan. Limitations of 
this study include small sample sizes, the possibility of confounding factors that are not 
controlled, so that research with larger scales is needed to confirm this result. 
5 Conclusion 
There was a statistically significant decrease in MDA levels in obese patients undergoing 
Ramadhan fasting and a significant decrease in body weight, waist size, hip size, and 
statistically the waist / hip size ratio and BMI in obese patients undergoing Ramadhan fasting. 
There was an improved profile lipids in the form of a decrease in total cholesterol levels, an 
increase in HDL and a statistically significant HDL-C / TC ratio  in obese patients undergoing 
Ramadhan fasting, while LDL levels also decrease but not statistically significant, there is a 
significant decrease in body weight both at tarawih <15 days and tarawih> 15 days. There was a 
significant decrease in BMI and hip size in tarawih <15 days and a very significant decrease in 
study subjects with tarawih> 15 days. There was a significant decrease in MDA levels in 
research subjects with tarawih> 15 days. There is no significant correlation between changes in 
BMI with changes in lipid profile and MDA. There is no significant correlation in changes in 
BMI with changes in BMI. 
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